Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort

Simon, Dagmar; Lübbe, Jann; Wüthrich, Brunello; Wiesner, Alice; Weber, M Monika; Laffitte, Emmanuel; Anliker, Mark D; Schöni, Martin H; Braathen, Lasse R; Schmid-Grendelmeier, Peter; Gilgen Bobalj, Nicole; Schneider, Dirk (2006). Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort. Dermatology, 213(4), pp. 313-8. Basel: Karger 10.1159/000096195

[img]
Preview
Text
000096195.pdf - Published Version
Available under License Publisher holds Copyright.

Download (246kB) | Preview

BACKGROUND: Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use. OBJECTIVE: To evaluate the efficacy, tolerability and cosmetic acceptance of a pimecrolimus-based regimen in daily practice in Switzerland. METHODS: This was a 6-month, open-label, multicentre study in 109 patients (55% > or = 18 years) with atopic dermatitis. Pimecrolimus cream 1% was incorporated into patients' standard treatment protocols. RESULTS: The pimecrolimus-based treatment was well tolerated and produced disease improvement in 65.7% of patients. It was particularly effective on the face (improvement rate: 75.0%). Mean pimecrolimus consumption decreased from 6.4 g/day (months 1-3) to 4.0 g/day (months 3-6) as disease improved. Most patients (74.1%) rated their disease control as 'complete' or 'good' and 90% were highly satisfied with the cream formulation. CONCLUSION: The use of a pimecrolimus-based regimen in everyday practice was effective, well tolerated and well accepted by patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Simon, Dagmar, Braathen, Lasse Roger

ISSN:

1018-8665

ISBN:

17135737

Publisher:

Karger

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:46

Last Modified:

21 Jun 2023 12:06

Publisher DOI:

10.1159/000096195

PubMed ID:

17135737

Web of Science ID:

000242372000008

BORIS DOI:

10.48350/18892

URI:

https://boris.unibe.ch/id/eprint/18892 (FactScience: 1158)

Actions (login required)

Edit item Edit item
Provide Feedback